Who Paid My Doc
Uvadex
Drug Critical Care
NDC 64067-216-01
General payments
$576,014
Research payments
$320,172
Through program year 2025, $576,014 in general payments and $320,172 in research payments were reported against Uvadex (Critical Care).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $218,082 | 227 |
| 2024 | General | $179,028 | 105 |
| 2023 | General | $96,771 | 109 |
| 2022 | General | $22,733 | 27 |
| 2021 | General | $28 | 1 |
| 2020 | General | $5,500 | 5 |
| 2020 | Research | $97,199 | 6 |
| 2019 | General | $53,872 | 36 |
| 2019 | Research | $222,973 | 29 |
Breakdown
The top 5 of 69 recipients; each share is of general payments naming this product in 2025.
The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 20 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
510 general · 35 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.